Page last updated: 2024-10-29

indirubin-3'-monoxime and Cavernous Angioma, Central Nervous System

indirubin-3'-monoxime has been researched along with Cavernous Angioma, Central Nervous System in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Otten, C1
Knox, J1
Boulday, G1
Eymery, M1
Haniszewski, M1
Neuenschwander, M1
Radetzki, S1
Vogt, I1
Hähn, K1
De Luca, C1
Cardoso, C1
Hamad, S1
Igual Gil, C1
Roy, P1
Albiges-Rizo, C1
Faurobert, E1
von Kries, JP1
Campillos, M1
Tournier-Lasserve, E1
Derry, WB1
Abdelilah-Seyfried, S1

Other Studies

1 other study available for indirubin-3'-monoxime and Cavernous Angioma, Central Nervous System

ArticleYear
Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations.
    EMBO molecular medicine, 2018, Volume: 10, Issue:10

    Topics: Animals; Caenorhabditis elegans; Cytological Techniques; Endothelial Cells; Gene Expression Profilin

2018